Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

First Gene Therapy Approved for Hearing Loss

First Gene Therapy Approved for Hearing Loss
ShareXFacebook

(MedPage Today) -- The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene therapy, lunsotogene parvec...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement